INCY Competitors & Alternatives
Compare Incyte Corporation with similar stocks in the same industry
Biotechnology
INCY
Main Stock$118.86
Tradestie Score
59
Market Cap
$16.93B
P/E Ratio
16.2
Revenue Growth
0.4%
Analyst Upside
+3.4%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$312.01
|
$36.81B | 74.0 | 53 | Compare |
|
INSM
Insmed, Inc.
|
$98.63
|
$31.13B | - | 47 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$92.95
|
$24.57B | - | 51 | Compare |
|
GMAB
Genmab A/S ADS
|
$28.67
|
$19.56B | 21.7 | 50 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.34
|
$15.70B | 31.2 | 58 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$13.21
|
$15.22B | - | 57 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$245.10
|
$12.36B | 29.2 | 54 | Compare |
|
EXEL
Exelixis Inc
|
$54.57
|
$11.09B | 18.5 | 47 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$33.13
|
$10.76B | - | 56 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$56.01
|
$10.74B | - | 51 | Compare |
More INCY Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 8731)
229 stocks in this industry